Concepedia

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, George P. Stathopoulos, C. Nicolaides, Anna Kalogera‐Fountzila, Haralabos P. Kalofonos, Angelos Nikolaou, C. Bacoyiannis, Epaminontas Samantas, C. Papadimitriou, P. Kosmidis,

Annals of Oncology · 1999 · 19 citations · 9 references

DOIFull text

Open access

Concepts

References

9

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Charlotte Jacobs, Gary H. Lyman, E Vélez-García et al. · Journal of Clinical Oncology · 1992 · 633 citations

, , +11

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 259 citations

, , +7

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck

Arlene A. Forastiere, Darleen Shank, Donna Neuberg et al. · Cancer · 1998 · 200 citations

, , +15

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jan B. Vermorken, M. Clavel et al. · Annals of Oncology · 1994 · 136 citations

, , +7

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin

PB Jensen, Bente Holm, IJ Christensen et al. · British Journal of Cancer · 1997 · 108 citations · Full text

, , +17